A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (VICTORIA)
The purpose of this research study is to determine the safety and effectiveness of an experimental study drug (MK-1242) for the treatment of heart failure.
- Visit with your doctor about 12 times throughout the study (1.5 - 3.5 years)
- Take study medication as directed
- Visits may include: blood samples, a physical exam, and optional heart imaging procedures
- Heart failure
Can be done from home
KeywordsHeart failure - overview, Coronary heart disease, Cardiomyopathy
Principal InvestigatorJuan Vilaro, MD
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.